{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:17:19Z","timestamp":1740107839309,"version":"3.37.3"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s10157-016-1360-y","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T03:50:35Z","timestamp":1480305035000},"page":"27-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Management of phosphorus load in CKD patients"],"prefix":"10.1007","volume":"21","author":[{"given":"Yutaka","family":"Taketani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Koiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6122-592X","authenticated-orcid":false,"given":"Keitaro","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"key":"1360_CR1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1681\/ASN.2008020141","volume":"20","author":"RN Foley","year":"2009","unstructured":"Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol. 2009;20:397\u2013404.","journal-title":"J Am Soc Nephrol"},{"key":"1360_CR2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.02101205","volume":"1","author":"S Schwarz","year":"2006","unstructured":"Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP. Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol. 2006;1:825\u201331.","journal-title":"Clin J Am Soc Nephrol."},{"key":"1360_CR3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1681\/ASN.2008040349","volume":"20","author":"KL Adeney","year":"2009","unstructured":"Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol. 2009;20:381\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"1360_CR4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/ndt\/gfi236","volume":"21","author":"M Sigrist","year":"2006","unstructured":"Sigrist M, Bungay P, Taal MW, McIntyre CW. Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant. 2006;21:707\u201314.","journal-title":"Nephrol Dial Transplant"},{"key":"1360_CR5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/heartjnl-2011-300570","volume":"98","author":"CD Chue","year":"2012","unstructured":"Chue CD, Edwards NC, Moody WE, Steeds RP, Townend JN, Ferro CJ. Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: a cardiac magnetic resonance study. Heart. 2012;98:219\u201324.","journal-title":"Heart"},{"key":"1360_CR6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2215\/CJN.04100808","volume":"4","author":"JH Ix","year":"2009","unstructured":"Ix JH, De Boer IH, Peralta CA, Adeney KL, Duprez DA, Jenny NS, Siscovick DS, Kestenbaum BR. Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA. Clin J Am Soc Nephrol. 2009;4:609\u201315.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1360_CR7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.ajkd.2011.11.007","volume":"59","author":"MI Yilmaz","year":"2012","unstructured":"Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Mallamaci F, Zoccali C. Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial. Am J Kidney Dis. 2012;59:177\u201385.","journal-title":"Am J Kidney Dis"},{"key":"1360_CR8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/ki.2013.547","volume":"86","author":"KL Naylor","year":"2014","unstructured":"Naylor KL, McArthur E, Lesilie WD, Fraser LA, Jamal SA, Cadarette SM, Pouget JG, Lok CE, Hodsman AB, Adachi JD, Garg AX. The three-year incidence of fracture in chronic kidney disease. Kidney Int. 2014;86:810\u20138.","journal-title":"Kidney Int"},{"key":"1360_CR9","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.2215\/CJN.00810110","volume":"5","author":"H Eddington","year":"2010","unstructured":"Eddington H, Hoefield R, Sinha S, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Mallamaci F, Zoccali C. Serum phosphate and mortality in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:2251\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1360_CR10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.amjmed.2012.08.018","volume":"126","author":"JJ Sim","year":"2013","unstructured":"Sim JJ, Bhandari SK, Smith N, Chung J, Liu IL, Jacobsen SJ, Kalantar-Zadeh K. Phosphorus and risk of renal failure in subjects with normal renal function. Am J Med. 2013;126:311\u20138.","journal-title":"Am J Med"},{"key":"1360_CR11","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS, Guti\u00e9rrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, Hamm L, Gadegbeku C, Horwitz E, Townsend RR, Anderson CA, Lash JP, Hsu CY, Leonard MB, Wolf M. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011;79:1370\u20138.","journal-title":"Kidney Int"},{"key":"1360_CR12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71:31\u20138.","journal-title":"Kidney Int"},{"key":"1360_CR13","first-page":"S1","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;113:S1\u2013130.","journal-title":"Kidney Int Suppl"},{"key":"1360_CR14","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15:2208\u201318.","journal-title":"J Am Soc Nephrol"},{"key":"1360_CR15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","volume":"70","author":"K Kalantar-Zadeh","year":"2006","unstructured":"Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 2006;70:771\u201380.","journal-title":"Kidney Int"},{"key":"1360_CR16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","volume":"16","author":"B Kestenbaum","year":"2005","unstructured":"Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol. 2005;16:520\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"1360_CR17","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/ndt\/gfv099","volume":"30","author":"JL Fernandez-Martin","year":"2015","unstructured":"Fernandez-Martin JL, Martinez-Camblor P, Dionisi MP, Floege J, Ketteler M, London G, Locatelli F, Gorriz JL, Rutkowski B, Ferreira A, Bos WJ, Covic A, Rodr\u00edguez-Garc\u00eda M, S\u00e1nchez JE, Rodr\u00edguez-Puyol D, Cannata-Andia JB, COSMOS group. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transplant. 2015;30:1542\u201351.","journal-title":"Nephrol Dial Transplant"},{"key":"1360_CR18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2215\/CJN.06080809","volume":"5","author":"K Kalantar-Zadeh","year":"2010","unstructured":"Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, Noori N, Hirschberg R, Benner D, Nissenson AR, Kopple JD, Kalantar-Zadeh K. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:519\u201330.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1360_CR19","first-page":"553","volume":"56","author":"Japanese Society of Nephrology","year":"2014","unstructured":"Japanese Society of Nephrology. Dietary recommendation for chronic kidney disease 2014. Jpn J Nephrol. 2014;56:553\u201399.","journal-title":"Jpn J Nephrol"},{"key":"1360_CR20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2215\/CJN.07640711","volume":"7","author":"B Iorio Di","year":"2012","unstructured":"Di Iorio B, Di Micco L, Torraca S, Sirico ML, Russo L, Pota A, Mirenghi F, Russo D. Acute effects of very-low-protein diet on FGF23 levels: a randomized study. Clin J Am Soc Nephrol. 2012;7:581\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1360_CR21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MCO.0000000000000171","volume":"18","author":"Y Obi","year":"2015","unstructured":"Obi Y, Qader H, Kovesdy CP, Kalantar-Zadeh K. Latest consensus and update on protein-energy wasting in chronic kidney disease. Curr Opin Clin Nutr Metab Care. 2015;18:254\u201362.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1360_CR22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/j.ajkd.2014.09.029","volume":"65","author":"AP Shah","year":"2015","unstructured":"Shah AP, Kalantar-Zadeh K, Kopple JD. Is there a role for ketoacid supplements in the management of CKD? Am J Kidney Dis. 2015;65:659\u201373.","journal-title":"Am J Kidney Dis"},{"key":"1360_CR23","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s40279-014-0176-8","volume":"44","author":"BS Cheema","year":"2014","unstructured":"Cheema BS, Chan D, Fahey P, Atlantis E. Effect of progressive resistance training on measures of skeletal muscle hypertrophy, muscular strength and health-related quality of life in patients with chronic kidney disease: a systematic review and meta-analysis. Sports Med. 2014;44:1125\u201338.","journal-title":"Sports Med"},{"key":"1360_CR24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13539-014-0140-3","volume":"5","author":"DL Kirkman","year":"2014","unstructured":"Kirkman DL, Mullins P, Junglee NA, Kumwenda M, Jibani MM, Macdonald JH. Anabolic exercise in haemodialysis patients: a randomised controlled pilot study. J Cachexia Sarcopenia Muscle. 2014;5:199\u2013207.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1360_CR25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2215\/CJN.08601209","volume":"5","author":"N Noori","year":"2010","unstructured":"Noori N, Kalantar-Zadeh K, Kovesdy CP, Bross R, Benner D, Kopple JD. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2010;5:683\u201392.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1360_CR26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1755-6686.2011.00212.x","volume":"37","author":"LM Taylor","year":"2011","unstructured":"Taylor LM, Kalantar-Zadeh K, Markewich T, Colman S, Benner D, Sim JJ, Kovesdy CP. Dietary egg whites for phosphorus control in maintenance haemodialysis patients: a pilot study. J Ren Care. 2011;37:16\u201324.","journal-title":"J Ren Care"},{"key":"1360_CR27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2147\/PPA.S43486","volume":"7","author":"K Kalantar-Zadeh","year":"2013","unstructured":"Kalantar-Zadeh K. Patient education for phosphorus management in chronic kidney disease. Patient Prefer Adher. 2013;7:379\u201390.","journal-title":"Patient Prefer Adher"},{"key":"1360_CR28","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1023\/A:1026224101580","volume":"25","author":"XG Lei","year":"2003","unstructured":"Lei XG, Porres JM. Phytase enzymology, applications, and biotechnology. Biotechnol Lett. 2003;25:1787\u201394.","journal-title":"Biotechnol Lett"},{"key":"1360_CR29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2215\/CJN.05040610","volume":"6","author":"SM Moe","year":"2011","unstructured":"Moe SM, Zidehsarai MP, Chambers MA, Jackman LA, Radcliffe JS, Trevino LL, Donahue SE, Asplin JR. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:257\u201364.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1360_CR30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/jam.12204","volume":"115","author":"LH Markiewicz","year":"2013","unstructured":"Markiewicz LH, Honke J, Haros M, \u015awi\u0105tecka D, Wr\u00f3blewska B. Diet shapes the ability of human intestinal microbiota to degrade phytate\u2014in vitro studies. J Appl Microbiol. 2013;115:247\u201359.","journal-title":"J Appl Microbiol"},{"key":"1360_CR31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.2009.96","volume":"301","author":"C Sullivan","year":"2009","unstructured":"Sullivan C, Sayre SS, Leon JB, Machekano R, Love TE, Porter D, Marbury M, Sehgal AR. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA. 2009;301:629\u201335.","journal-title":"JAMA"},{"key":"1360_CR32","unstructured":"The Ministry of Health, Labor, and Welfare. The National Health and Nutrition Survey 2014. http:\/\/www.mhlw.go.jp\/stf\/houdou\/0000067890.html . Accessed 20 Sep 2016."},{"key":"1360_CR33","unstructured":"The Ministry of Health, Labor and Welfare. Surveys on daily intake levels of food additives by market basket method 2013. http:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/shokuhin\/syokuten\/sesshu\/index.html . Accessed 20 Sep 2016"},{"key":"1360_CR34","first-page":"2255","volume":"33","author":"Y Shutto","year":"2013","unstructured":"Shutto Y, Yamabe H, Shimada M, Murakami R, Fujita T, Nakamura N. Lack of awareness of phosphate in processed food and drinks among patients with chronic kidney disease. Prog Med. 2013;33:2255\u20139.","journal-title":"Prog Med"},{"key":"1360_CR35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1053\/j.jrn.2009.01.014","volume":"19","author":"MH Hager","year":"2009","unstructured":"Hager MH, Geiger C, Hill LJ, Martin C, Weiner S, Chianchiano D. Usefulness of nutrition facts label for person with chronic kidney disease. J Ren Nutr. 2009;19:204\u201310.","journal-title":"J Ren Nutr"},{"key":"1360_CR36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.jrn.2011.04.004","volume":"22","author":"H Karp","year":"2012","unstructured":"Karp H, Ekholm P, Kemi V, Itkonen S, Hirvoen T, N\u00e4rkko S, Lamberg-Allardt C. Differences among total and in vitro digestive phosphorus content of plant foods and beverages. J Ren Nutr. 2012;22:416\u201322.","journal-title":"J Ren Nutr"},{"issue":"62","key":"1360_CR37","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1021\/jf404187n","volume":"12","author":"O Benini","year":"2014","unstructured":"Benini O, Saba A, Ferretti V, Gianfaldoni D, Kalantar-Zadeh K, Cupisti A. Development and analytical evaluation of a spectrophotometric procedure for the quantification of different types of phosphorus in meat products. J Agric Food Chem. 2014;12(62):1247\u201353.","journal-title":"J Agric Food Chem"},{"key":"1360_CR38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.jrn.2005.10.005","volume":"16","author":"A Cupisti","year":"2006","unstructured":"Cupisti A, Comar F, Luoetti S, D\u2019Alessandro C, Barsootti G, Gianfaldoni D. Effect of boiling on dietary phosphate and nitrogen intake. J Ren Nutr. 2006;16:36\u201340.","journal-title":"J Ren Nutr"},{"key":"1360_CR39","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1053\/j.jrn.2015.05.005","volume":"25","author":"S Ando","year":"2015","unstructured":"Ando S, Sakuma M, Morimoto Y, Arai H. The effect of various boiling conditions on reduction of phosphorus and protein in meat. J Ren Nutr. 2015;25:504\u20139.","journal-title":"J Ren Nutr"},{"key":"1360_CR40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/j.jrn.2014.11.002","volume":"25","author":"I Vrdoljak","year":"2015","unstructured":"Vrdoljak I, Panjkota Krbav\u010di\u0107 I, Bituh M, Vrdoljak T, Dujmi\u0107 Z. Analysis of different thermal processing methods of foodstuffs to optimize protein, calcium, and phosphorus content for dialysis patients. J Ren Nutr. 2015;25:308\u201315.","journal-title":"J Ren Nutr"},{"key":"1360_CR41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.nut.2009.10.009","volume":"27","author":"C Delgado-Andrade","year":"2011","unstructured":"Delgado-Andrade C, Seiquer I, Gracia MM, Galdo G, Navarro MP. Increased intake of Maillard reaction products reduces phosphorus digestibility in male adolescents. Nutrition. 2011;27:86\u201391.","journal-title":"Nutrition"},{"key":"1360_CR42","first-page":"89","volume":"4","author":"N Noori","year":"2010","unstructured":"Noori N, Sims JJ, Kopple JD, Shah A, Colman S, Shinaberger CS, Bross R, Mehrotra R, Kovesdy CP, Kalantar-Zadeh K. Organic and inorganic dietary phosphorus and its management in chronic kidney disease. Iran J Kidney Dis. 2010;4:89\u2013100.","journal-title":"Iran J Kidney Dis"},{"key":"1360_CR43","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.3177\/jnsv.61.S173","volume":"61","author":"Y Taketani","year":"2015","unstructured":"Taketani Y, Masuda M, Yamanaka-Okumura H, Tatsumi S, Segawa H, Miyamoto K, Takeda E, Yamamoto H. Niacin and chronic kidney disease. J Nutr Sci Vitaminol (Tokyo). 2015;61:S173\u20135.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"1360_CR44","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1038\/sj.ki.5002000","volume":"70","author":"Y Nishida","year":"2006","unstructured":"Nishida Y, Taketani Y, Yamanaka-Okumura H, Imamura F, Taniguchi A, Sato T, Shuto E, Nashiki K, Arai H, Yamamoto H, Takeda E. Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int. 2006;70:2141\u20137.","journal-title":"Kidney Int"},{"key":"1360_CR45","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tifs.2012.01.004","volume":"26","author":"JPM Duynhoven van","year":"2012","unstructured":"van Duynhoven JPM, van Velzen EJJ, Westerhuis JA, Foltz M, Jacobs DM, Smilde AK. Nutrikinetics: concept, technologies, applications, perspectives. Trends Food Sci Technol. 2012;26:4\u201313.","journal-title":"Trends Food Sci Technol"},{"issue":"2","key":"1360_CR46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1744-9987.2010.00898.x","volume":"15","author":"T Shigematsu","year":"2011","unstructured":"Shigematsu T, Tokumoto A, Nakaoka A, Arisaka H. Effect of lanthanum carbonate treatment on bone in Japanese dialysis patients with hyperphosphatemia. Ther Apher Dial. 2011;15(2):176\u201384.","journal-title":"Ther Apher Dial"},{"key":"1360_CR47","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","volume":"382","author":"SA Jamal","year":"2013","unstructured":"Jamal SA, Vandermeer B, Raggi P, Mendelssohn DC, Chatterley T, Dorgan M, Lok CE, Fitchett D, Tsuyuki RT. Effect of calcium-based versus noncalcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet. 2013;382:1268\u201377.","journal-title":"Lancet"},{"key":"1360_CR48","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","volume":"23","author":"GA Block","year":"2012","unstructured":"Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, Allison MA, Asplin J, Smits G, Hoofnagle AN, Kooienga L, Thadhani R, Mannstadt M, Wolf M, Chertow GM. Effects of phosphate binders in moderate CKD. J Am Soc Nephrol. 2012;23:1407\u201315.","journal-title":"J Am Soc Nephrol"},{"key":"1360_CR49","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.03820411","volume":"7","author":"B Iorio Di","year":"2012","unstructured":"Di Iorio B, Bellasi A, Russo D, INDEPENDENT Study Investigators. Mortality in kidney disease patients treated with phosphate binders: a randomized study. Clin J Am Soc Nephrol. 2012;7:487\u201393.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1360_CR50","doi-asserted-by":"crossref","first-page":"c3691","DOI":"10.1136\/bmj.c3691","volume":"341","author":"MJ Bolland","year":"2010","unstructured":"Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691.","journal-title":"BMJ"},{"key":"1360_CR51","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","volume":"83","author":"KM Hill","year":"2013","unstructured":"Hill KM, Martin BR, Wastney ME, McCabe GP, Moe SM, Weaver CM, Peacock M. Oral calcium carbonate affects calcium but not phosphorus balance in stage 3\u20134 chronic kidney disease. Kidney Int. 2013;83:959\u201366.","journal-title":"Kidney Int"},{"key":"1360_CR52","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2014.10.014","volume":"65","author":"GA Block","year":"2015","unstructured":"Block GA, Fishbane S, Rodriguez M, Smits G, Shemesh S, Pergola PE, Wolf M, Chertow GM. A 12-week, doubleblind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD stages 3\u20135. Am J Kidney Dis. 2015;65:728\u201336.","journal-title":"Am J Kidney Dis"},{"key":"1360_CR53","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.mnh.0000447020.74593.6f","volume":"23","author":"M Wolf","year":"2014","unstructured":"Wolf M, White KE. Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease. Curr Opin Nephrol Hypertens. 2014;23:411\u20139.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4 Suppl 3","key":"1360_CR54","first-page":"S1","volume":"42","author":"Kidney F National","year":"2003","unstructured":"National Kidney F. K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 Suppl 3):S1\u2013201.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1360_CR55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1744-9987.12058","volume":"17","author":"M Fukagawa","year":"2013","unstructured":"Fukagawa M, Yokoyama K, Koiwa F, Taniguchi M, Shoji T, Kazama JJ, Komaba H, Ando R, Kakuta T, Fujii H, Nakayama M, Shibagaki Y, Fukumoto S, Fujii N, Hattori M, Ashida A, Iseki K, Shigematsu T, Tsukamoto Y, Tsubakihara Y, Tomo T, Hirakata H, Akizawa T, CKD-MBD Guideline Working Group, Japanese Society for Dialysis Therapy. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial. 2013;17(3):247\u201388.","journal-title":"Ther Apher Dial"},{"key":"1360_CR56","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(12)70364-5","volume":"15","author":"EG Lowrie","year":"1990","unstructured":"Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990;15:458\u201382.","journal-title":"Am J Kidney Dis"},{"key":"1360_CR57","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium\u00a0\u00d7\u00a0phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31:607\u201317.","journal-title":"Am J Kidney Dis"},{"key":"1360_CR58","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","volume":"12","author":"SK Ganesh","year":"2001","unstructured":"Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), Ca\u00a0\u00d7\u00a0PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. 2001;12:2131\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"1360_CR59","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.ASN.0000113243.24155.2F","volume":"15","author":"LA Stevens","year":"2004","unstructured":"Stevens LA, Djurdjev O, Cardew S, Cameron EC, Levin A. Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol. 2004;15:770\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"1360_CR60","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","volume":"67","author":"EW Young","year":"2005","unstructured":"Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Pattern Study. Kidney Int. 2005;67:1179\u201387.","journal-title":"Kidney Int"},{"key":"1360_CR61","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1681\/ASN.2004040275","volume":"16","author":"Y Slinin","year":"2005","unstructured":"Slinin Y, Foley RN, Collins AJ. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol. 2005;16:1788\u201393.","journal-title":"J Am Soc Nephrol"},{"key":"1360_CR62","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.ajkd.2005.04.006","volume":"46","author":"A Rodriguez-Benot","year":"2005","unstructured":"Rodriguez-Benot A, Martin-Malo A, Alvarez-Lara MA, Rodriguez M, Aljama P. Mild hyperphosphatemia and mortality in hemodialysis patients. Am J Kidney Dis. 2005;46:68\u201377.","journal-title":"Am J Kidney Dis"},{"key":"1360_CR63","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/j.ajkd.2005.08.013","volume":"46","author":"M Noordzij","year":"2005","unstructured":"Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT. Netherlands Cooperative Study on the Adequacy of Dialysis: the Kidney Disease Outcomes Quality Initiative (K\/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis. 2005;46:925\u201332.","journal-title":"Am J Kidney Dis"},{"key":"1360_CR64","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","volume":"26","author":"J Floege","year":"2011","unstructured":"Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, Kronenberg F, Marcelli D, Passlick-Deetjen J, Schernthaner G, Fouqueray B, Wheeler DC. ARO Investigators: serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant. 2011;26:1948\u201355.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1360_CR65","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/1744-9987.12030","volume":"17","author":"M Taniguchi","year":"2013","unstructured":"Taniguchi M, Fukagawa M, Fujii N, Hamano T, Shoji T, Yokoyama K, Nakai S, Shigematsu T, Iseki K, Tsubakihara Y, Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy. Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients. Ther Apher Dial. 2013;17(2):221\u20138.","journal-title":"Ther Apher Dial"},{"issue":"3","key":"1360_CR66","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2215\/CJN.04620510","volume":"6","author":"KE Lynch","year":"2011","unstructured":"Lynch KE, Lynch R, Curhan GC, Brunelli SM. Prescribed dietary phosphate restriction and survival among hemodialysis patients. Clin J Am Soc Nephrol. 2011;6(3):620.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"1360_CR67","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/1744-9987.12378","volume":"19","author":"I Masakane","year":"2015","unstructured":"Masakane I, Nakai S, Ogata S, Kimata N, Hanafusa N, Hamano T, Wakai K, Wada A, Nitta K. An overview of regular dialysis treatment in Japan (as of 31 December 2013). Ther Apher Dial. 2015;19(6):540\u201374.","journal-title":"Ther Apher Dial"},{"key":"1360_CR68","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3945\/ajcn.2008.26665","volume":"88","author":"CS Shinaberger","year":"2008","unstructured":"Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, Kalantar-Zadeh K. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr. 2008;88:1511\u20138.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"1360_CR69","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1053\/j.ajkd.2015.03.036","volume":"66","author":"SC Palmer","year":"2015","unstructured":"Palmer SC, Gardner S, Tonelli M, Mavridis D, Johnson DW, Craig JC, French R, Ruospo M, Strippoli GF. Association of drug effects on serum parathyroid hormone, phosphorus, and calcium levels with mortality in CKD: a meta-analysis. Am J Kidney Dis. 2015;66(6):962\u201371.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"1360_CR70","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","volume":"20","author":"T Isakova","year":"2009","unstructured":"Isakova T, Guti\u00e9rrez OM, Chang Y, Shah A, Tamez H, Smith K, Thadhani R, Wolf M. Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol. 2009;20(2):388.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1360_CR71","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.jrn.2014.03.006","volume":"24","author":"K Yokoyama","year":"2014","unstructured":"Yokoyama K, Akiba T, Fukagawa M, Nakayama M, Sawada K, Kumagai Y, Chertow GM, Hirakata H. Long-term safety and efficacy of a novel iron-containing phosphate binder, JTT-751, in patients receiving hemodialysis. J Ren Nutr. 2014;24(4):261\u20137.","journal-title":"J Ren Nutr"},{"key":"1360_CR72","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12891","author":"F Koiwa","year":"2016","unstructured":"Koiwa F, Yokoyama K, Fukagawa M, Terao A, Akizawa T. Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphatemia: a randomised, open-label, multicentre, 12-week phase III study. Nephrology (Carlton). 2016;. doi: 10.1111\/nep.12891 (Epub ahead of print).","journal-title":"Nephrology (Carlton)"},{"key":"1360_CR73","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw042","author":"A Lenglet","year":"2016","unstructured":"Lenglet A, Liabeuf S, El Esper N, Brisset S, Mansour J, Lemaire-Hurtel AS, Mary A, Brazier M, Kamel S, Mentaverri R, Choukroun G, Fournier A, Massy ZA. Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study. Nephrol Dial Transplant. 2016. doi: 10.1093\/ndt\/gfw042 .","journal-title":"Nephrol Dial Transplant."},{"key":"1360_CR74","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2215\/CJN.09050815","volume":"11","author":"GA Block","year":"2016","unstructured":"Block GA, Rosenbaum DP, Leonsson-Zachrisson M, Stefansson BV, Ryd\u00e9n-Bergsten T, Greasley PJ, Johansson SA, Knutsson M, Carlsson BC. Effect of tenapanor on interdialytic weight gain in patients on hemodialysis. Clin J Am Soc Nephrol. 2016;11:1597\u2013605.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"1360_CR75","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1053\/j.ajkd.2014.04.028","volume":"64","author":"AR Chang","year":"2014","unstructured":"Chang AR, Grams ME. Serum phosphorus and mortality in the Third National Health and Nutrition Examination Survey (NHANES III): effect modification by fasting. Am J Kidney Dis. 2014;64(4):567\u201373.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"1360_CR76","doi-asserted-by":"crossref","first-page":"E2036","DOI":"10.1210\/jc.2012-2024","volume":"97","author":"K Yoda","year":"2012","unstructured":"Yoda K, Imanishi Y, Yoda M, Mishima T, Ichii M, Yamada S, Mori K, Emoto M, Inaba M. Impaired response of FGF-23 to oral phosphate in patients with type 2 diabetes: a possible mechanism of atherosclerosis. J Clin Endocrinol Metab. 2012;97(11):E2036\u201343.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1360-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-016-1360-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1360-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T02:17:31Z","timestamp":1657851451000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-016-1360-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,28]]},"references-count":76,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["1360"],"URL":"https:\/\/doi.org\/10.1007\/s10157-016-1360-y","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"type":"print","value":"1342-1751"},{"type":"electronic","value":"1437-7799"}],"subject":[],"published":{"date-parts":[[2016,11,28]]}}}